pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4271 |
Genomic Coordinates | chr3: 49274120 - 49274186 |
Description | Homo sapiens miR-4271 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4271 | ||||||||||||||||||
Sequence | 39| GGGGGAAGAAAAGGUGGGG |57 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | SOLiD | DRVs in miRNA |
|
||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | RBPJL | ||||||||||||||||||||
Synonyms | RBPL, RBPSUHL, SUHL | ||||||||||||||||||||
Description | recombination signal binding protein for immunoglobulin kappa J region like | ||||||||||||||||||||
Transcript | NM_014276 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on RBPJL | |||||||||||||||||||||
3'UTR of RBPJL (miRNA target sites are highlighted) |
>RBPJL|NM_014276|3'UTR 1 GCGCGCCCGGTAGCCCCGGCTGCCCACCCTGGAGGGCTGCGCCCGCGCCAGGCGCGGGGACGTGTTTCTGGGTTCTAGGC 81 CCTGCTTCCTTGCCCCTTTGCTGCAGAAGGGCAGCTGAAGGCTCACCCTAGAAACCGGGCCTGGTGGGTCTTACCCGGCT 161 CACTCCCTCCCTTGTCCTTACACATACAGGAAGACAAGACCTGAGTGGTGCTGTCTTTGTGTCCGTCGTGTATGGCTCTC 241 CCTGTCTTCATTTCTTCTCACTCTGTCTCTAAACCTCTCTCTCTCTCCCTTCCCCCTCAGTACTTAGTCTACAGACCTAT 321 GTGCGTGTCCCTATCCTTCTGTCCTTTTCTCTCTTCAGCTCTCCCTGCCTCTCACACACAATTTTACATGCCCCGAGGAG 401 CCAAGTTTGGGACATTTACCCTCCAGGCATCTGTGTCCCCTCTTGAAGAGAAAACACACAGCTTCACACATCCAGGCATA 481 GGGGGCAAGCTCTTGGGGCATCAGGACCCTGGAGCACCAGGTCCTTCCTGGAATATTAGATCCACCTGGAGCACCGGGTC 561 TCTCTAAGTCTCACCTGGGGAATTCGGTCCCACCTGGGGCACCAGTTCCCACCTAGAGCACTGTGTCCTGCCCTAGAGCA 641 CAAAGACCTGCTCCTCCCGAGACTCTCTCTGACTGCAGCCAGGCATAGTACCTTTGCCTGTGTTTGCTCCCTGGTCCACA 721 GATTTGGTGGCTGGGCAGGTGCCTGGACAGTGATGAGGTCTTGCCGCCTTAACTGTCCCCCCCAGTCACTTCTCCCACAG 801 GCCCAGCAGGACGCAGTCCTGAGGATCAGGGATTCTACAGCTGCATTAAAATCAATCCTATCCAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | MCF7 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset GSM4903825 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID14_NS |
Location of target site | NM_014276 | 3UTR | CUCCCUUCCCCCUCAGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000372741.3 | 3UTR | ACCUCUCUCUCUCUCCCUUCCCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
181 hsa-miR-4271 Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT066209 | MARCH9 | membrane associated ring-CH-type finger 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT079367 | CCDC137 | coiled-coil domain containing 137 | ![]() |
![]() |
2 | 2 | ||||||
MIRT081183 | MIDN | midnolin | ![]() |
![]() |
2 | 4 | ||||||
MIRT083278 | ZCCHC3 | zinc finger CCHC-type containing 3 | ![]() |
![]() |
2 | 6 | ||||||
MIRT086207 | HOXD13 | homeobox D13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT133713 | SKI | SKI proto-oncogene | ![]() |
![]() |
2 | 4 | ||||||
MIRT150653 | SLC27A1 | solute carrier family 27 member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT159166 | NRBP1 | nuclear receptor binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT160059 | TET3 | tet methylcytosine dioxygenase 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT180856 | RPRD2 | regulation of nuclear pre-mRNA domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT181931 | MARK2 | microtubule affinity regulating kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT190628 | BCL2L2-PABPN1 | BCL2L2-PABPN1 readthrough | ![]() |
![]() |
2 | 2 | ||||||
MIRT190654 | PABPN1 | poly(A) binding protein nuclear 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT196107 | MPRIP | myosin phosphatase Rho interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT263248 | SGPL1 | sphingosine-1-phosphate lyase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT321168 | EIF4H | eukaryotic translation initiation factor 4H | ![]() |
![]() |
2 | 2 | ||||||
MIRT338624 | SHMT2 | serine hydroxymethyltransferase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT366301 | GDI1 | GDP dissociation inhibitor 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT375172 | ARIH1 | ariadne RBR E3 ubiquitin protein ligase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT441488 | NCEH1 | neutral cholesterol ester hydrolase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT442333 | WNT9B | Wnt family member 9B | ![]() |
![]() |
2 | 2 | ||||||
MIRT443889 | CNKSR3 | CNKSR family member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT445880 | WBP1L | WW domain binding protein 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT449312 | MRO | maestro | ![]() |
![]() |
2 | 2 | ||||||
MIRT449844 | BCL2L13 | BCL2 like 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT450304 | DRAXIN | dorsal inhibitory axon guidance protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT450515 | EMX1 | empty spiracles homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT451243 | ZNF444 | zinc finger protein 444 | ![]() |
![]() |
2 | 2 | ||||||
MIRT451713 | OLR1 | oxidized low density lipoprotein receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT451792 | TLR5 | toll like receptor 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT451823 | ALDH3B1 | aldehyde dehydrogenase 3 family member B1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT451906 | ILK | integrin linked kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT452181 | KIAA1456 | KIAA1456 | ![]() |
![]() |
2 | 4 | ||||||
MIRT452242 | TRAM1 | translocation associated membrane protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452544 | ZNF467 | zinc finger protein 467 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452605 | REPIN1 | replication initiator 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454505 | ZFYVE27 | zinc finger FYVE-type containing 27 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454657 | FBXL18 | F-box and leucine rich repeat protein 18 | ![]() |
![]() |
2 | 2 | ||||||
MIRT455354 | KDM5C | lysine demethylase 5C | ![]() |
![]() |
2 | 2 | ||||||
MIRT455452 | EPB41L4B | erythrocyte membrane protein band 4.1 like 4B | ![]() |
![]() |
2 | 2 | ||||||
MIRT455587 | TAF12 | TATA-box binding protein associated factor 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT456501 | PFKFB2 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT456815 | PIGP | phosphatidylinositol glycan anchor biosynthesis class P | ![]() |
![]() |
2 | 2 | ||||||
MIRT457425 | NOL10 | nucleolar protein 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT457468 | SLC35F6 | solute carrier family 35 member F6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT457660 | SERINC1 | serine incorporator 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT458231 | NXPH3 | neurexophilin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT458374 | ITM2C | integral membrane protein 2C | ![]() |
![]() |
2 | 2 | ||||||
MIRT458667 | GPR35 | G protein-coupled receptor 35 | ![]() |
![]() |
2 | 2 | ||||||
MIRT459665 | VPS37C | VPS37C, ESCRT-I subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT459825 | TPP1 | tripeptidyl peptidase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT460564 | FEM1A | fem-1 homolog A | ![]() |
![]() |
2 | 2 | ||||||
MIRT460725 | ASXL3 | additional sex combs like 3, transcriptional regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT461121 | RAB36 | RAB36, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT461529 | C14orf1 | ergosterol biosynthesis 28 homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT461750 | DDX11 | DEAD/H-box helicase 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT462570 | STS | steroid sulfatase | ![]() |
![]() |
2 | 2 | ||||||
MIRT462798 | NTN1 | netrin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT463030 | ZNF689 | zinc finger protein 689 | ![]() |
![]() |
2 | 2 | ||||||
MIRT463991 | WDTC1 | WD and tetratricopeptide repeats 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT464684 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT465439 | TP53 | tumor protein p53 | ![]() |
![]() |
2 | 2 | ||||||
MIRT465512 | PRICKLE4 | prickle planar cell polarity protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT465649 | TNPO2 | transportin 2 | ![]() |
![]() |
2 | 10 | ||||||
MIRT465947 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | ![]() |
![]() |
2 | 2 | ||||||
MIRT466028 | TMEM189 | transmembrane protein 189 | ![]() |
![]() |
2 | 2 | ||||||
MIRT468076 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | ![]() |
![]() |
2 | 6 | ||||||
MIRT468131 | SH3PXD2A | SH3 and PX domains 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT468498 | SESN2 | sestrin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT468879 | RREB1 | ras responsive element binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT469318 | RGP1 | RGP1 homolog, RAB6A GEF complex partner 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT469558 | RARA | retinoic acid receptor alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT469793 | RAB15 | RAB15, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT469896 | PTRF | caveolae associated protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT470235 | PRRC2A | proline rich coiled-coil 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT470808 | PLXND1 | plexin D1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT471597 | PAQR5 | progestin and adipoQ receptor family member 5 | ![]() |
![]() |
2 | 10 | ||||||
MIRT471710 | OTUB1 | OTU deubiquitinase, ubiquitin aldehyde binding 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT471752 | OGT | O-linked N-acetylglucosamine (GlcNAc) transferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT472978 | MRRF | mitochondrial ribosome recycling factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT473538 | MAX | MYC associated factor X | ![]() |
![]() |
2 | 2 | ||||||
MIRT473581 | MAT2A | methionine adenosyltransferase 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT473970 | LRRC58 | leucine rich repeat containing 58 | ![]() |
![]() |
2 | 2 | ||||||
MIRT474223 | LCOR | ligand dependent nuclear receptor corepressor | ![]() |
![]() |
2 | 4 | ||||||
MIRT474553 | KLHDC3 | kelch domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT474777 | KIAA0895L | KIAA0895 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT476042 | GRSF1 | G-rich RNA sequence binding factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT476438 | GBA2 | glucosylceramidase beta 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT477773 | E2F3 | E2F transcription factor 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT477946 | DPM2 | dolichyl-phosphate mannosyltransferase subunit 2, regulatory | ![]() |
![]() |
2 | 2 | ||||||
MIRT478782 | CRTC2 | CREB regulated transcription coactivator 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT479320 | VPS72 | vacuolar protein sorting 72 homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT480405 | C19orf47 | chromosome 19 open reading frame 47 | ![]() |
![]() |
2 | 2 | ||||||
MIRT480593 | BTRC | beta-transducin repeat containing E3 ubiquitin protein ligase | ![]() |
![]() |
2 | 2 | ||||||
MIRT480963 | BBC3 | BCL2 binding component 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT481127 | AZIN1 | antizyme inhibitor 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT481444 | ARRB2 | arrestin beta 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT481687 | AR | androgen receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT481730 | APH1A | aph-1 homolog A, gamma-secretase subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT482386 | AEN | apoptosis enhancing nuclease | ![]() |
![]() |
2 | 2 | ||||||
MIRT482564 | ABHD2 | abhydrolase domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT482605 | ABHD14B | abhydrolase domain containing 14B | ![]() |
![]() |
2 | 2 | ||||||
MIRT483256 | CITED4 | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4 | ![]() |
![]() |
2 | 4 | ||||||
MIRT483531 | TAGLN2 | transgelin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT483840 | UNC5B | unc-5 netrin receptor B | ![]() |
![]() |
2 | 4 | ||||||
MIRT483935 | LENG8 | leukocyte receptor cluster member 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT484414 | SNX19 | sorting nexin 19 | ![]() |
![]() |
2 | 2 | ||||||
MIRT484487 | SLC9A1 | solute carrier family 9 member A1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT484609 | SIX3 | SIX homeobox 3 | ![]() |
![]() |
2 | 6 | ||||||
MIRT484703 | RNF11 | ring finger protein 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT485244 | POGZ | pogo transposable element derived with ZNF domain | ![]() |
![]() |
2 | 2 | ||||||
MIRT485607 | FOSL1 | FOS like 1, AP-1 transcription factor subunit | ![]() |
![]() |
2 | 4 | ||||||
MIRT485965 | RTBDN | retbindin | ![]() |
![]() |
2 | 2 | ||||||
MIRT487308 | GLTSCR1 | BRD4 interacting chromatin remodeling complex associated protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT487329 | SREBF1 | sterol regulatory element binding transcription factor 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT487410 | CACNB1 | calcium voltage-gated channel auxiliary subunit beta 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT487607 | C20orf96 | chromosome 20 open reading frame 96 | ![]() |
![]() |
2 | 2 | ||||||
MIRT487689 | CDK14 | cyclin dependent kinase 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT487787 | GPR20 | G protein-coupled receptor 20 | ![]() |
![]() |
2 | 4 | ||||||
MIRT488026 | ADO | 2-aminoethanethiol dioxygenase | ![]() |
![]() |
2 | 2 | ||||||
MIRT488476 | B3GALNT2 | beta-1,3-N-acetylgalactosaminyltransferase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT488761 | FXYD1 | FXYD domain containing ion transport regulator 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT489161 | MRPL12 | mitochondrial ribosomal protein L12 | ![]() |
![]() |
2 | 4 | ||||||
MIRT489529 | MRE11A | MRE11 homolog, double strand break repair nuclease | ![]() |
![]() |
2 | 8 | ||||||
MIRT489774 | GRINA | glutamate ionotropic receptor NMDA type subunit associated protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT489878 | MPLKIP | M-phase specific PLK1 interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT490094 | FN3K | fructosamine 3 kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT490202 | PKNOX2 | PBX/knotted 1 homeobox 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT490283 | ISL2 | ISL LIM homeobox 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT490377 | LHFPL3 | LHFPL tetraspan subfamily member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT491035 | ALPK3 | alpha kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT491186 | JUND | JunD proto-oncogene, AP-1 transcription factor subunit | ![]() |
![]() |
2 | 4 | ||||||
MIRT491766 | ZNF385A | zinc finger protein 385A | ![]() |
![]() |
2 | 2 | ||||||
MIRT491888 | YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon | ![]() |
![]() |
2 | 2 | ||||||
MIRT491981 | UNK | unkempt family zinc finger | ![]() |
![]() |
2 | 2 | ||||||
MIRT492400 | SDK1 | sidekick cell adhesion molecule 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT493647 | HDLBP | high density lipoprotein binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT494010 | DUSP9 | dual specificity phosphatase 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT494167 | CNOT6L | CCR4-NOT transcription complex subunit 6 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT495712 | PADI1 | peptidyl arginine deiminase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT496873 | AHCYL2 | adenosylhomocysteinase like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT499175 | RBPJL | recombination signal binding protein for immunoglobulin kappa J region like | ![]() |
![]() |
2 | 2 | ||||||
MIRT501652 | PHLDA3 | pleckstrin homology like domain family A member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT506645 | MAPK1 | mitogen-activated protein kinase 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT510590 | TUBB2A | tubulin beta 2A class IIa | ![]() |
![]() |
2 | 6 | ||||||
MIRT511907 | FKBP1A | FK506 binding protein 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT513063 | ANKRD45 | ankyrin repeat domain 45 | ![]() |
![]() |
2 | 2 | ||||||
MIRT513104 | DYNAP | dynactin associated protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT521804 | POM121C | POM121 transmembrane nucleoporin C | ![]() |
![]() |
2 | 2 | ||||||
MIRT523520 | GLUL | glutamate-ammonia ligase | ![]() |
![]() |
2 | 2 | ||||||
MIRT525085 | FRK | fyn related Src family tyrosine kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT530930 | SCIN | scinderin | ![]() |
![]() |
2 | 2 | ||||||
MIRT533501 | TRIM71 | tripartite motif containing 71 | ![]() |
![]() |
2 | 2 | ||||||
MIRT538560 | CECR2 | CECR2, histone acetyl-lysine reader | ![]() |
![]() |
2 | 2 | ||||||
MIRT544556 | CSNK2A1 | casein kinase 2 alpha 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT555912 | ORMDL3 | ORMDL sphingolipid biosynthesis regulator 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT560405 | TMEM69 | transmembrane protein 69 | ![]() |
![]() |
2 | 2 | ||||||
MIRT560664 | RTN3 | reticulon 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT564061 | CDT1 | chromatin licensing and DNA replication factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565504 | SP1 | Sp1 transcription factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT570014 | COL1A2 | collagen type I alpha 2 chain | ![]() |
![]() |
2 | 2 | ||||||
MIRT572321 | HSPB6 | heat shock protein family B (small) member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT573229 | TRIM21 | tripartite motif containing 21 | ![]() |
![]() |
2 | 2 | ||||||
MIRT573487 | IQSEC3 | IQ motif and Sec7 domain 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT574137 | MARVELD1 | MARVEL domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT574323 | ZNF703 | zinc finger protein 703 | ![]() |
![]() |
2 | 2 | ||||||
MIRT620939 | OSMR | oncostatin M receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT650080 | MTL5 | testis expressed metallothionein like protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT684553 | ZNF708 | zinc finger protein 708 | ![]() |
![]() |
2 | 2 | ||||||
MIRT685841 | ANGEL1 | angel homolog 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT688551 | DCAF16 | DDB1 and CUL4 associated factor 16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT701985 | MIER3 | MIER family member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT703899 | EPT1 | selenoprotein I | ![]() |
![]() |
2 | 2 | ||||||
MIRT706388 | MC2R | melanocortin 2 receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT707487 | UGT2B4 | UDP glucuronosyltransferase family 2 member B4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT711885 | INSIG2 | insulin induced gene 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT719164 | KIF6 | kinesin family member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT721294 | C3orf36 | chromosome 3 open reading frame 36 | ![]() |
![]() |
2 | 2 | ||||||
MIRT721775 | ARL6IP4 | ADP ribosylation factor like GTPase 6 interacting protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT723763 | NKIRAS2 | NFKB inhibitor interacting Ras like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT725485 | GPR26 | G protein-coupled receptor 26 | ![]() |
![]() |
2 | 2 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|